Jan Nolta
Institution Name:
University of California, Davis
Total Awards:
1
Award Value:
$2,615,674
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Early Translational I | University of California, Davis | Sustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders | $2,615,674 |
Total: $2,615,674.00 |
Awards as Co-PI
| Early Translational II | Bone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds |
| Disease Team Therapy Development - Research | MSC engineered to produce BDNF for the treatment of Huntington's disease |
| Disease Team Therapy Development - Research | Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia |
Publications
- Mol Ther 2011 Generation of HIV-1 Resistant and Functional Macrophages From Hematopoietic Stem Cell-derived Induced Pluripotent Stem Cells. (PubMed: 21119622)
- Tissue Eng Part A 2010 shRNA-mediated decreases in c-Met levels affect the differentiation potential of human mesenchymal stem cells and reduce their capacity for tissue repair. (PubMed: 20367286)
- Stem Cells 2010 Stem Cells' position statement on hESC research. (PubMed: 20809560)
- Stem Cells 2012 Editorial: Our Top 10 Developments in Stem Cell Biology over the Last 30 Years. (PubMed: 22162299)
- Stem Cell Rev 2012 Role of miRNAs in Neuronal Differentiation from Human Embryonic Stem Cell-Derived Neural Stem Cells. (PubMed: 23054963)
